| 1 |
31537377 | Gp130 degradation induced by epirubicin contributes to chemotherapy efficacy. | 2019 Nov 12 |
1 |
| 2 |
29541177 | RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells. | 2018 Apr |
3 |
| 3 |
28423359 | Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy. | 2017 Jul 11 |
1 |
| 4 |
27272157 | Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer. | 2016 Sep |
1 |
| 5 |
25759054 | [Pharmacological study and pharmaceutical intervention to reduce intravenous injection-induced vascular injury]. | 2015 |
1 |
| 6 |
22330067 | Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury. | 2012 Apr 15 |
4 |
| 7 |
22802261 | The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment. | 2012 Sep |
6 |
| 8 |
19781349 | [Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells]. | 2009 Jun |
2 |